Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
P34947
UPID:
GRK5_HUMAN
Alternative names:
G protein-coupled receptor kinase GRK5
Alternative UPACC:
P34947; D3DRD0; Q5T059
Background:
G protein-coupled receptor kinase 5 (GRK5) is a serine/threonine kinase with a pivotal role in phosphorylating activated forms of GPCRs, leading to receptor desensitization, internalization, and down-regulation. It targets a wide array of GPCRs including adrenergic, muscarinic acetylcholine, dopamine, and opioid receptors. Beyond GPCRs, GRK5 phosphorylates substrates like TP53/p53, HDAC5, and ARRB1, influencing apoptosis, transcription regulation, and MAPK signaling.
Therapeutic significance:
Understanding the role of G protein-coupled receptor kinase 5 could open doors to potential therapeutic strategies.